Prognostic implication of troponin I elevation after percutaneous coronary intervention

American Journal of Cardiology

Volumn 91, Issue 10, 2003, Pages 1272-1274

  Nallamothu, Brahmajee K ^a   Chetcuti, Stanley ^a   Mukherjee, Debabrata ^a   Grossman, P Michael ^a   Kline Rogers, Eva ^a   Werns, Steven W ^a   Bates, Eric R ^a   Moscucci, Mauro ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN I;

ADULT; AGED; ARTICLE; ATHERECTOMY; CARDIOVASCULAR RISK; CORONARY ARTERY SURGERY; CORONARY STENT; CORRELATION ANALYSIS; DEATH; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT SATISFACTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; Q WAVE; SURVIVAL; THROMBECTOMY;

EID: 0038064096     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00283-2     Document Type: Article

References (17)

1. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention a device-specific analysis of 7147 patients . Circulation. 104:2001;642-647.
2. Akkerhuis K.M., Alexander J.H., Tardiff B.E., Boersma E., Harrington R.A., Lincoff A.M., Simoons M.L. Minor myocardial damage and prognosis are spontaneous and percutaneous coronary intervention-related events different? Circulation. 105:2002;554-556.
3. Califf R.M., Abdelmeguid A.E., Kuntz R.E., Popma J.J., Davidson C.J., Cohen E.A., Kleiman N.S., Mahaffey K.W., Topol E.J., Pepine C.J., et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 31:1998;241-251.
4. Brener S.J., Ellis S.G., Schneider J., Topol E.J. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J. 23:2002;869-876.
5. Saucedo J.F., Mehran R., Dangas G., Hong M.K., Lansky A., Kent K.M., Satler L.F., Pichard A.D., Stone G.W., Leon M.B. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol. 35:2000;1134-1141.
6. Ellis S.G., Chew D., Chan A., Whitlow P.L., Schneider J.P., Topol E.J. Death following creatine kinase-MB elevation after coronary intervention identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy . Circulation. 106:2002;1205-1210.
7. Tardiff B.E., Califf R.M., Tcheng J.E., Lincoff A.M., Sigmon K.N., Harrington R.A., Mahaffey K.W., Ohman E.M., Teirstein P.S., Blankenship J.C., Kitt M.M., Topol E.J. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol. 33:1999;88-96.
8. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 94:1996;1528-1536.
9. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA. 277:1997;461-466.
10. Kugelmass A.D., Cohen D.J., Moscucci M., Piana R.N., Senerchia C., Kuntz R.E., Baim D.S. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 74:1994;748-754.
11. Coudrey L. The troponins. Arch Intern Med. 158:1998;1173-1180.
12. Fuchs S., Kornowski R., Mehran R., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Clark C.E., Stone G.W., Leon M.B. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol. 85:2000;1077-1082.
13. Cantor W.J., Newby L.K., Christenson R.H., Tuttle R.H., Hasselblad V., Armstrong P.W., Moliterno D.J., Califf R.M., Topol E.J., Ohman E.M. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol. 39:2002;1738-1744.
14. Bertinchant J.P., Polge A., Ledermann B., Genet L., Fabbro-Peray P., Raczka F., Brunet J., Poirey S., Wittenberg O., Pernel I., Nigond J. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol. 84:1999;51-57.
15. Garbarz E., Iung B., Lefevre G., Makita Y., Farah B., Michaud P., Graine H., Vahanian A. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol. 84:1999;515-518.
16. Moscucci M., Kline-Rogers E., Share D., O'Donnell M., Maxwell-Eward A., Meengs W.L., Kraft P., DeFranco A.C., Chambers J.L., Patel K., McGinnity J.G., Eagle K.A. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation. 104:2001;263-268.
17. Anderson H.V., Shaw R.E., Brindis R.G., Hewitt K., Krone R.J., Block P.C., McKay C.R., Weintraub W.S. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol. 39:2002;1096-1103.